Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 2
2008 2
2010 5
2011 2
2012 6
2013 5
2014 5
2015 8
2016 7
2017 5
2018 5
2019 4
2020 8
2021 15
2022 12
2023 8
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Kelley RK, et al. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Lancet. 2023. PMID: 37075781 Free article. Clinical Trial.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M; CheckMate 577 Investigators. Kelly RJ, et al. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. N Engl J Med. 2021. PMID: 33789008 Clinical Trial.
Controversies in upper GI oncology: early-onset gastric cancer.
Petrillo A, Alsina M, Ben-Aharon I. Petrillo A, et al. Among authors: ben aharon i. ESMO Open. 2024 May;9(5):102925. doi: 10.1016/j.esmoop.2024.102925. Epub 2024 Apr 24. ESMO Open. 2024. PMID: 38663169 Free PMC article. No abstract available.
Young-Onset Cancers-Early Steps in the Right Direction.
Barreto SG, Ben-Aharon I. Barreto SG, et al. Among authors: ben aharon i. Cancers (Basel). 2023 May 4;15(9):2599. doi: 10.3390/cancers15092599. Cancers (Basel). 2023. PMID: 37174065 Free PMC article.
Evolving treatment paradigms in esophageal cancer.
Turgeman I, Ben-Aharon I. Turgeman I, et al. Among authors: ben aharon i. Ann Transl Med. 2021 May;9(10):903. doi: 10.21037/atm.2020.03.110. Ann Transl Med. 2021. PMID: 34164537 Free PMC article. Review.
Gender Gap in Leadership of Clinical Trials.
Waldhorn I, Bomze D, Ben-Aharon I, Schlosser S, Markel G, Ludmir EB, Meirson T. Waldhorn I, et al. Among authors: ben aharon i. JAMA Intern Med. 2023 Dec 1;183(12):1406-1408. doi: 10.1001/jamainternmed.2023.5104. JAMA Intern Med. 2023. PMID: 37902723 Free PMC article.
104 results